Synergistic effect of glucosamine and vitamin E against experimental rheumatoid arthritis in neonatal rats

Area of Science:

• Biochemistry
• Pharmacology
• Immunology

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease.
• Neonatal rat models are utilized to study RA pathogenesis and potential treatments.
• Oxidative stress and inflammation play critical roles in RA development.

Purpose of the Study:

• To investigate the therapeutic effects of glucosamine and vitamin E combination on rheumatoid arthritis.
• To evaluate the impact of this supplementation on various biochemical and inflammatory markers in a neonatal rat model.

Main Methods:

• A neonatal rat model of rheumatoid arthritis was established.
• Levels of lipid peroxidation, antioxidant enzymes (SOD, catalase, GSH, Gpx), inflammatory mediators (MMP-3, PGE2, NO, iNOS), and other biochemical markers (ceruloplasmin, copper, zinc, uric acid) were measured.
• Protein levels of NF-κB and iNOS were assessed.

Main Results:

• Glucosamine plus vitamin E significantly reduced lipid peroxidation (MDA) by 61.9%.
• Supplementation increased antioxidant enzyme activities (SOD, catalase, GSH, Gpx) and zinc levels.
• Levels of MMP-3, PGE2, ceruloplasmin, copper, NO, uric acid, NF-κB, and iNOS were significantly decreased.

Conclusions:

• Glucosamine and vitamin E exert a synergistic protective effect against rheumatoid arthritis in this model.
• The combination therapy effectively modulates oxidative stress and inflammatory pathways implicated in RA.
• This suggests a potential therapeutic benefit of glucosamine and vitamin E for managing rheumatoid arthritis.